have proved that the disease is transmitted to man by a certain wood tick, Dermacentor venustus, which receives the virus from infected wild rodents, principally gophers or Columbian ground squirrels and jack-rabbits (Wilson and Chowning; Parker). Ricketts"°was the first to transmit the disease from man to guinea pigs and monkeys by injecting the blood drawn from spotted fever patients and, after having fed normal ticks on the infected guinea pigs, to reproduce the disease again in normal guinea pigs by allowing the infected ticks to feed on the animals. The virus of Rocky Mountain spotted fever can be maintained in the laboratory for an indefinite time by animal passage, which makes its experimental study possible. Several strains of the passage virus 1 l maintained in the guinea pig were employed in the present series of studies on immunity. Ricketts and Gomez' 2 found that the serum from guinea pigs which had recovered from the disease would protect normal guinea pigs from infection when administered within 2 to 3 days after the injection of the infecting material. The strength of the serum was such that 0.3 to 0.5 cc. was required to protect against 1 cc. of virus (1,000 infecting doses), and these investigators were unable to enhance the Entomol., Circular 1 (Revised), 1921 . 3rd Biennial Rep., Montana State Bd. Entomol., 1917 -18, 1919 4th Biennial Rep., Montana State Bd. Entomol., 1919 -20, 1921 9 Wolbach, S. B., Studies on Rocky Mountain spotted fever, J. Med. Research, 1919-20, xli, 1. ] 0 Ricketts, H. T., The study of "Rocky Mountain spotted fever" (tick fever?) by means of animal inoculations. A preliminary communication, J. Am. Med. Assn., 1906, xlvii, 33 12 Ricketts, H. T., and Gomez, L., Studies on immunity in Rocky Mountain spotted fever. The preventive and curative action of a serum for spotted fever, and the inefficiency of sodium cacodylate as a curative agent for this disease in guinea-pigs, J. Infect. Dis., 1908, v, 221. potency by repeatedly injecting an immune animal with virus. They accordingly drew the tentative conclusion that the usefulness of the serum in human cases would be practically nil, especially since the amount required would be prohibitive when translated into terms of human body weight. Ricketts' work was not completed, however, and there seem to be no experimental data to indicate how a serum of this kind might be developed so as to be of practical value. The purpose of the experiments recorded here was to study this problem and if possible to produce an immune serum of at least sufficient potency to be useful when the time of infection is definitely known and the injection of serum can be made soon after the inoculation of the virus, as when a laboratory worker is bitten by an infected tick or accidentally inoculates himself with an instrument charged with infected material.
Although the serum of guinea pigs which have passed through a severe infection has a degree of neutralizing power when injected at the same time as the virus, it is not strong enough to check the course of the infection when introduced 24 to 48 hours later. In the present series of experiments, however, it has been found that the neutralizing power of the serum is considerably increased by one or two more subsequent inoculations of the virus, in citrated blood, into the convalescent guinea pig, and sera prepared in this way are capable of modifying the course of the disease into a non-fatal one or, in some instances, of suppressing the infection completely, provided the serum is administered during the incubation period.
The small size of the guinea pig precludes the possibility of utilizing its immune serum for human cases, but the principle developed from the experiments with the serum of guinea pigs suggested that larger animals might be capable of furnishing an equally potent immune serum in correspondingly greater amounts. Ricketts and Gomez,' 2 and later Heinemann and Moore,13 reported having infected horses by injecting large quantities of virus from guinea pigs or monkeys. Although the horses showed some fever on the 3rd or 4th day after inoculation, it never reached 104 0 F. and usually lasted only 1 day. The serum from the horses, however, was stated to possess some neutralizing power as compared with normal horse serum.
1' Heinemann, P. G., and Moore, J. J., Experimental therapy of Rocky Mountain spotted fever, J. Infect. Dis., 1912, x, 294. 
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ROCKY MOUNTAIN SPOTTED FEVER. I EXPERIMENTAL.
The writer's experiments with horses have so far been unsuccessful. Two adult horses were given intravenous injections of blood from infected guinea pigs in doses ranging from 20 to 50 cc. at intervals of 3 to 5 days, and a colt 6 months old received similar injections of larger amounts (35 to 95 cc.) of the virus. The rise of temperature to 103-104°F. which occurred on the 3rd or 4th day after inoculation was interpreted as being due to the introduction of a large quantity of blood corpuscles from a foreign species. The animals never showed symptoms suggestive of spotted fever, and the serum on test was found to have only slight neutralizing power for the virus; 1 cc. was necessary to neutralize about 10 M.L.D. when administered simultaneously.
In view of the facts that adult ticks feed on horses and cattle, and that a certain number of ticks collected at random prove to be infective, it was thought of interest to test the serum of horses which had been pastured in infected districts. Serum from a horse which had been pastured for several years in the Bitter Root Valley was obtained' 4 and tested against the virus. As shown in Table I The only animal which yields a useful serum, both in potency and quantity, is the rabbit. In the first place, the rabbit is susceptible to the virus of spotted fever. The infection is usually non-fatal, the febrile period lasting for 6 to 9 days, though it is sometimes shorter or longer. The scrotal skin may show the typical capillary thrombosis and subsequent necrosis. After recovery the animal becomes completely resistant to subsequent infection, and 0.5 to 0.1 cc. of the serum, collected 2 weeks after disappearance of symptoms, is capable of rendering non-fatal an infection produced by 100 M.L.D. of the virus, the test animal in every instance being the guinea pig. By another intravenous injection of virulent blood, e.g. of 4 cc., or 400 M.L.D., the serum can be raised in potency five-to tenfold, and in some instances to such a titer that 0.1 cc. will neutralize 1,000 M.L.D. The reinforcing injection is given 2 weeks after complete recovery of the animal, and the immune serum is drawn 9 days later. A serum, whether convalescent or reinforced, is sufficiently strong for practical use when it is capable in a dose of 0.1 cc. of neutralizing 100 M.L.D. of the virus. As will be seen from the results recorded in Tables II to IV, the immune rabbit serum prevents the development of the infection or renders it non-fatal when administered within the period of incubation-the earlier the administration of the serum the more complete the suppression of the infection.
Male guinea pigs of 500 gm. body weight were used. The virus ' " consisted of the citrated blood from the heart of guinea pigs on the 4th or 5th day of fever and was inoculated subcutaneously. 1 cc., equivalent to 100 M.L.D., was given in Experiment 1, 0.1 cc. (10 M.L.D.) in Experiment 2, and 0.01 cc. (1 M.L.D.) in Experiment 3. Eighteen guinea pigs were used in each series, two animals being inoculated with the immune serum immediately after the injection of the virus, and two at the end of 24, 48, 72, and 96 hours, and 5, 6, and 7 days. The remaining two animals served as controls without serum. The immune serum used was a mixture of sera from several immunized rabbits and was given in a dose of 1 cc. in Experiments 1 and 2 and 0.1 cc. in Experiment 3. The titer of the pooled serum was such that when given simultaneously 1 cc. completely neutralized 100 M.L.D., 0.1 and 0.01 cc. modified the infection to a non-fatal one, while 0.001 cc. exerted no influence upon the course of the infection. The serum was given subcutaneously. As Table II shows, 1 cc. of the serum, given within 24 hours from the time of introduction of a massive amount (100 M.L.D.) of the virus into the body of the guinea pig, is capable of suppressing the infection; when given later, but before 96 hours (near the time of onset of the disease), this quantity does not suppress the infection but renders it non-fatal. After 5 days, that is when the disease is already manifest, no benefit seemed to be derived from administration of the serum, the animals dying within 12 to 17 days (the controls died within 12 to 13 days).
The results in the second series (Table III) are similar, except that, owing probably to the smaller quantity of the virus used (10 M.L.D.), the infection was completely suppressed in all animals which received the serum within the first 48 hours. All those which received it after 48 hours, but within 96 hours, survived, after passing through a mild infection without any scrotal or other cutaneous lesions. Administration of the serum later than 5 days invariably failed to prevent a fatal outcome, the animals dying just as the controls did.
In the third series (Table IV) , in which only 1 M.L.D. was used to infect the animals, the protective effect of the immune serum was 389 with the serum after 5, 6, and 7 days respectively, the infection was mild, undoubtedly because the serum was given before the animals showed any fever, while they were still in the incubation period, which is decidedly longer in the case of 1 M.L.D. than when 10 or 100 M.L.D. are inoculated.
DISCUSSION AND SUMMARY.
From the results of the experiments presented it is evident that in guinea pigs an early administration of immune rabbit serum will suppress the infection; that is, if it is given within the period of incubation, the effect being proportionately greater the earlier the serum is administered. Almost no beneficial effect is observed when the serum is given after the onset of the disease. In the animals inoculated with 10 to 100 M.L.D. the incubation period is shorter than when 1 M.L.D. is injected; nevertheless 1 cc. of the immune serum saved the animals as late as 96 hours from the time of the introduction of the virus into the system. When administered within 24 hours in the case of 100 M.L.D. and within 48 hours in the case of 10 M.L.D., the serum completely neutralized the virus, and the animals escaped infection altogether. On the other hand, the same quantity of the serum only modified the infection into a non-fatal one when given a day or two later. In the animals which were inoculated with 1 M.L.D. the incubation period was a day or two longer, and the neutralizing effect of the serum was much more powerful. Here animals were saved as late as 5, 6, and 7 days and with a much smaller quantity of the serum (0.1 cc.).
As to the usefulness of such an immune serum in human cases, the relative susceptibility of man and the guinea pig must first be considered. In a large number of experimental infections carried out with guinea pigs in the past 6 years almost never has a naturally refractory animal been encountered. The mortality is nearly 80 per cent with most strains, although as low as 50 per cent with some. The strain used in the present study caused death in nearly 80 per cent of the animals. Hence the susceptibility of guinea pigs is at least as great as that of man, in whom the mortality in the Bitter Root Valley is estimated to be about 70 per cent.'? 9
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The relative length of the incubation period in guinea pig and in man is another point which requires analysis. In guinea pigs it varies somewhat according to the number of passages, being as short as 3 days when 100 M.L.D. or more of an adapted virus are inoculated. On the other hand, when the infection is the result of 1 M.L.D. or the bite of an infected tick, the incubation period is much longer, being 5, 6, or 7 days in the former and 7 to 8 days in the latter instance, as with the present strain. In man the infection is brought on by the bite of an infected tick, and the period of incubation varies from 3 to 10 days but is usually 7 days; i.e., it is about the same as in guinea pigs infected with 1 M.L.D. Hence we may regard the susceptibility of man and the guinea pig as nearly equal.
The final point to be considered is the quantity of the immune serum that may be recommended for use in human cases. To prevent the infection in a guinea pig weighing 500 gm., 0.1 cc. of the serum was sufficient. This quantity protected the animal against 1 M.L.D. even as late as 5, 6, or 7 days. Calculated on this basis, 16 cc. of the serum would be required for a man weighing 80 kilos (about 160 pounds); that is, 16 cc. of an immune rabbit serum, administered before onset of the disease, should theoretically be sufficient to save a man of average weight against an infection brought about by the bite of an infected tick or by a laboratory accident. It would probably be best to administer the serum intravenously. The titer of the immune serum should be previously determined in guinea pigs, and 1 cc. should neutralize 100 M.L.D. completely and 0.1 and 0.01 cc. render the infection non-fatal. Such a serum is easily produced in rabbits (a rabbit weighing 2,500 gm. will yield 50 to 60 cc. of the serum) and probably will remain active a year or longer when kept at refrigerator temperature.
CONCLUSIONS.
A potent immune serum against the virus of Rocky Mountain spotted fever can be produced in the rabbit.
By early administration of such an immune serum the virus introduced into the guinea pig can be prevented from multiplying and causing fatal infection. When given within the period of incubation the suppression of the infection is assured, but after the onset of the disease the serum has no beneficial effect. In view of the comparative susceptibility of man and the guinea pig it is recommended that in every instance when the bite of a tick gives reason to suspect a possible infection with spotted fever, or when a person accidentally inoculates himself with the virus, about 0.2 cc. of the serum per kilo of body weight (or 0.1 cc. per pound) be injected immediately, preferably intravenously. For the average adult about 16 cc. should be given.
